MedImaging Integrated Solution Inc. (6796) fair value: what the stock is really worth
As of Oct 28, 2026: fair value (intrinsic value) of MedImaging Integrated Solution Inc. stock TWD 5.20, price TWD 51.60, upside -89.9%, quality 38 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Fair value 30%+ above price?No
Quality 50+?No
In an uptrend?No
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Oct 28, 2026.
How to read this chart
60‑month range 38.72 TWD – 125.82 TWD · fair‑value band 3.17 TWD – 7.06 TWD · the 51.60 TWD price screens above the 5.20 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 28, 2026.
Follow MedImaging Integrated Solution in your weekly email
Every Wednesday you see whether MedImaging Integrated Solution is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Medimaging Integrated Solution Inc. engages in the design, manufacture and sale of digital medical imaging diagnostic equipments. It also provides digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes, as well as auxiliary tools.
Show moreShow less
It also offers horus scope products, including optical coherence tomography products, control units, scopes, software, and accessories; computing-based AI screening solutions in diabetic retinopathy, wound care, and medical diagnosis; endoscopy solutions comprising a micro camera module for visualization performance and patient-oriented care; and micro camera modules.
The company was founded in 2010 and is headquartered in Hsinchu City, Taiwan.
Stock analysis
MedImaging Integrated Solution Inc. (6796) currently trades at 51.60 TWD, while our model-based Fair Value estimate is 5.20 TWD, 89.9% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 8.31 TWD per share, and 1 of the 17 models we run sit above the 51.60 TWD price.
Bear case: the Earnings-Based group reads lowest at 1.84 TWD, and 16 of the 17 models stay below the price. Data coverage for this calculation is low.
Scenario range: 3.17 TWD (bear) to 7.06 TWD (bull), the price of 51.60 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
MedImaging Integrated Solution Inc. reported revenue of 661M TWD in FY2025 versus 486M TWD in FY2021, a compound +8.0%/yr. Reported net income was 7.7M TWD in FY2025, compounding −41.6%/yr from FY2021.
Key figures
Market cap 2.1B TWD (≈ $63.8M) Micro · P/E ratio 132.3 · P/S ratio 3.04 · EPS (TTM) 0.3900 TWD · Dividend yield 0.5% · Net margin 2.1% · Return on equity 1.9% · Return on assets (EBIT) 5.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 24 out of 100 (medium confidence).
What moves the price
The share trades about 51% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −3% fair-value upside, at −90%, 6796 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (1.84 TWD to 80.26 TWD). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear3.17 TWDFair Value 5.20 TWDBull7.06 TWD
Price 51.60 TWD · Upside -89.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.1158 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.50/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+22.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.4%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.7%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−34.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year−34.7%
Dividend (yield on the price)0.5%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 3%
Compare MedImaging Integrated Solution Inc. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 322 stocks
Beats the industry median on 0/13 measures
Overall it trails its industry peers.
Valuation
Quality Score38 · Bottom 25%
Fair Value upside−89.9% · Bottom 25%
Profitability
Return on equity (12 months)1.9% · Below median
Return on assets0.5% · Below median
Net margin (12 months)2.1% · Below median
Operating margin (12 months)−5.9% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)4.4% · Below median
Dividend yield (12 months)0.5% · Bottom 25%
Balance sheet
Debt / equity0.44× · Highest 25%
Valuation Multiplesvs Medical Devices median · lower = cheaper
P/E (12 months)132.3× · Priciest 25%
P/B2.79× · Pricier than median
P/S (12 months)3.04× · Pricier than median
EV/EBITDA44.3× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 8
FUTURE (revenue growth)22· sector 34
PAST (return on equity)7· sector 17
HEALTH (low debt)78· sector 98
DIVIDEND (yield)10· sector 35
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "MedImaging Integrated Solution Inc. Fair Value". https://www.fairvalue-calculator.com/stock/6796
Frequently asked questions
Is MedImaging Integrated Solution Inc. (6796) overvalued or undervalued?
As of Oct 28, 2026, our model estimates a fair value of 5.20 TWD versus a price of 51.60 TWD, about −90% upside (overvalued).
What is the fair value of 6796?
Our model-based fair value for MedImaging Integrated Solution Inc. is 5.20 TWD (as of Oct 28, 2026), built from audited fundamentals. The current price: 51.60 TWD.
What is the quality score of 6796?
MedImaging Integrated Solution Inc. has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for MedImaging Integrated Solution Inc. (6796)?
Our model-based price target is the fair value of 5.20 TWD (as of Oct 28, 2026) from 17 valuation models. Cautious scenario 3.17 TWD, optimistic scenario 7.06 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the MedImaging Integrated Solution Inc. stock forecast for 2026?
Our models put fair value at 5.20 TWD, about −90% upside versus a price of 51.60 TWD (overvalued). Cautious scenario 3.17 TWD, optimistic scenario 7.06 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of MedImaging Integrated Solution Inc. (6796)?
MedImaging Integrated Solution Inc. reported trailing-twelve-month revenue of about 682M TWD (latest available figure, as of Oct 28, 2026).
Does MedImaging Integrated Solution Inc. pay a dividend?
MedImaging Integrated Solution Inc. currently shows a dividend yield of 0.48% relative to its recent price (as of Oct 28, 2026).
What is the intrinsic value of MedImaging Integrated Solution Inc. (6796)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For MedImaging Integrated Solution Inc. it is 5.20 TWD per share (as of Oct 28, 2026), against a price of 51.60 TWD. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is MedImaging Integrated Solution Inc. stock overvalued or undervalued in 2026?
As of Oct 28, 2026, 6796 trades above its calculated fair value: price 51.60 TWD, fair value 5.20 TWD, a gap of about −90% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6796?
No. The price is what the market pays today (51.60 TWD); the fair value is what the company's own numbers justify (5.20 TWD). For MedImaging Integrated Solution Inc. the two are 46.40 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is MedImaging Integrated Solution Inc. worth?
The market values MedImaging Integrated Solution Inc. at about 2.1B TWD (market capitalisation, as of Oct 28, 2026). Per share that is 51.60 TWD; our models calculate a fair value of 5.20 TWD per share.
What do the bullish and bearish scenarios say about 6796?
Our models span a range for MedImaging Integrated Solution Inc.: cautious scenario 3.17 TWD, base 5.20 TWD, optimistic 7.06 TWD per share (as of Oct 28, 2026, price 51.60 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6796?
MedImaging Integrated Solution Inc. trades at a price-to-earnings ratio of 132.3 (as of Oct 28, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 5.20 TWD is built from several models across several years. Other multiples: P/B 2.8, P/S 3.0, EV/EBITDA 44.3.
How solid is the balance sheet of MedImaging Integrated Solution Inc. (6796)?
Balance-sheet figures for MedImaging Integrated Solution Inc. (as of Oct 28, 2026): return on equity 1.9%, debt of 0.44 per unit of equity. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is 6796 from its 52-week high?
MedImaging Integrated Solution Inc. trades at 51.60 TWD, about 51% below its 52-week high of 105.00 TWD and 3% above the low of 50.20 TWD (as of Oct 28, 2026). Distance from the high says nothing about value: that is what the fair value of 5.20 TWD is for.
Which stocks are comparable to MedImaging Integrated Solution Inc.?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is MedImaging Integrated Solution Inc. stock attractive at the current price?
The data as of Oct 28, 2026: price 51.60 TWD, calculated fair value 5.20 TWD (−90%), Quality Score 38/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6796 calculated?
We run MedImaging Integrated Solution Inc. through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 5.20 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.4 % above its aggregate fair value. MedImaging Integrated Solution Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of MedImaging Integrated Solution Inc. (6796)?
The closing price on Oct 28, 2026 was 51.60 TWD. Our model-based fair value is 5.20 TWD, about −90% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with MedImaging Integrated Solution Inc. right now?
The price sits above even our optimistic bull case (7.06 TWD). The favourable scenario is already priced in. Weak quality (38/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (3.17 TWD to 7.06 TWD) leaves room in how you read the outcome.
Key figures of MedImaging Integrated Solution Inc.
How large is the market capitalisation of MedImaging Integrated Solution Inc. (6796)?
The market capitalisation of MedImaging Integrated Solution Inc. is 2.1B TWD (≈ $63.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of MedImaging Integrated Solution Inc. (6796)?
The price-to-sales ratio of MedImaging Integrated Solution Inc. is 3.04 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of MedImaging Integrated Solution Inc. (6796)?
Earnings per share at MedImaging Integrated Solution Inc. are 0.3900 TWD (price ÷ EPS = P/E 132.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of MedImaging Integrated Solution Inc. (6796)?
The dividend yield of MedImaging Integrated Solution Inc. is 0.5% (payout 64.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of MedImaging Integrated Solution Inc. (6796)?
The net margin of MedImaging Integrated Solution Inc. is 2.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of MedImaging Integrated Solution Inc. (6796)?
The return on equity (ROE) of MedImaging Integrated Solution Inc. is 1.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of MedImaging Integrated Solution Inc. (6796)?
On an EBIT basis the return on assets of MedImaging Integrated Solution Inc. is 5.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of MedImaging Integrated Solution Inc. (6796)?
The operating margin of MedImaging Integrated Solution Inc. is −5.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at MedImaging Integrated Solution Inc. (6796)?
Revenue at MedImaging Integrated Solution Inc. is growing +4.4% versus a year earlier (3y avg +9.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at MedImaging Integrated Solution Inc. (6796)?
Earnings per share at MedImaging Integrated Solution Inc. are growing −5.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does MedImaging Integrated Solution Inc. (6796) generate?
The free cash flow of MedImaging Integrated Solution Inc. is −46.7M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does MedImaging Integrated Solution Inc. (6796) carry?
The net debt of MedImaging Integrated Solution Inc. is 135M TWD (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch MedImaging Integrated Solution Inc. in the live analysis
One click puts MedImaging Integrated Solution Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 28, 2026